Review ArticlePractice

Management of secondary lymphedema related to breast cancer

Oren Cheifetz, Louise Haley and Breast Cancer Action
Canadian Family Physician December 2010; 56 (12) 1277-1284;

Abstract

OBJECTIVE To review recent literature on the management of secondary lymphedema following breast cancer.

QUALITY OF EVIDENCE MEDLINE, EMBASE, AMED, PubMed, and the Internet were searched for articles published between 2005 and 2009. Articles were evaluated using Sackett’s levels of evidence. The literature search focused on primary research and systematic reviews.

MAIN MESSAGE Secondary lymphedema related to breast cancer is an ongoing challenge. Evidence suggests that there are several safe and beneficial treatments, including complex decongestive therapy, physiotherapy, and exercise. Furthermore, resistive exercises, previously contraindicated on the affected side, have been found to be both beneficial and safe with careful progression and monitoring. Exercise guidelines and patient education topics are presented with a comprehensive reference list for further reading.

CONCLUSION Advances in cancer treatment, cancer and exercise research, and lymphedema management require that physicians have a basic understanding of the current evidence to provide appropriate patient education and referral.

In providing care to cancer patients and survivors, physicians might see patients presenting with secondary lymphedema, a condition in which fluid and protein accumulate in the extravascular interstitial spaces.1–3 Lymphedema is associated with feelings of discomfort and heaviness, functional limitation, disfigurement, psychological distress, and an elevated risk of recurrent infection.1,2,4 It has a negative effect on quality of life (QOL)4–6 and is probably the most feared complication of breast cancer treatment.1 Lymphedema complications can be long-lasting and are often considered to be “major.”1 Several risk factors contribute to the development or severity of secondary lymphedema (Table 1),2,3,7–14 including a higher body mass index, cellulitis, and delayed onset and duration of lymphedema.15 Background information is available in several systematic reviews.16–26

View this table:
Table 1.

Lymphedema risk factors and incidence

Lymphedema measurement

The most common methods of lymphedema measurement are bioelectrical impedance,27 volume displacement, and circumferential measurements. Ridner et al (2007)28 compared results from 2 types of bioimpedance instruments, infrared laser perometer, circumferential measurements, and the Lymphedema and Breast Cancer Questionnaire. They found high correlations (Pearson r 0.71 to 0.99, P < .001) among the tools and suggested that all could be used to assess lymphedema. Circumferential measurements were supported by Tewari et al (2008)29 and Taylor et al (2006).30 Volumes calculated from anatomic landmarks are reliable, valid, and more accurate than measurements based on distance from the fingers.30 Laser scanning techniques are also valid.31 Patients themselves play an important role in monitoring for lymphedema; however, subjective symptoms do not always correlate with measurable lymphedema.28 Lette (2006)32 and Lette et al (2007)33 describe a simple, home-based volume displacement measurement kit for patients.

No effective methods are described in the literature to measure edema affecting the head, neck, breast, trunk, or genitalia. Furthermore, inconsistencies in measurement methods have led to variability in the reporting of lymphedema incidence and prevalence, potentially affecting clinical practice.

Incidence and prevalence

The incidence of breast cancer–related lymphedema varies greatly in the literature, ranging from 2% to 83%,1,2,4,5,7 depending on the measurement tool used. Hayes et al (2008)2 found that, compared with bioimpedance spectroscopy, 40% to 60% of patients measured with circumferential or self-report tools went undetected. Further, a false diagnosis of lymphedema was given to 12% of those diagnosed using circumferential tools and 40% of those using self-report instruments.2 Other articles reported incidence rates of 33% to 48% following axillary lymph node dissection and radiation therapy (RT)34 and 5% to 14% after sentinel node biopsy and RT.35 In a Canadian study, the reported incidence was approximately 12%.7 In general, the prevalence of reported lymphedema ranges from 0.6% to 54%.1,2,11,36–39 Secondary lymphedema was more prevalent in patients who had radical mastectomy (20%) than in those who had breast-conserving surgery (8%).39 Additionally, patients who had axillary lymph node dissection reported a higher prevalence (27%) than those who had sentinel lymph node biopsy (3%).38

This article provides a review of the recent literature on the management of breast cancer–related lymphedema. As front-line health care providers, family physicians have a pivotal role in educating cancer patients about the risk of lymphedema, thereby potentially helping reduce the incidence and severity of this chronic condition.

Quality of evidence

Articles were found using a comprehensive search of several electronic databases, including MEDLINE, AMED (Allied and Complementary Medicine Database), EMBASE, and PubMed, restricted to recent publications (between 2005 and 2009) with an emphasis on primary research articles in English. The search terms lymphedema, cancer, neoplasm, exercise, physical activity, edema, and breast cancer were connected using and. This yielded 719 articles; all abstracts were reviewed and 135 full articles were read, most of which were primary research articles and systematic reviews. The primary articles were evaluated using Sackett’s levels of evidence,40,41 ranging from 1, the strongest evidence (systematic reviews of randomized controlled trials), to 5, the weakest evidence (expert opinion without explicit critical appraisal). Further information is available from the Centre for Evidence Based Medicine (www.cebm.net). An Internet search for references and clinical guidelines was also conducted.

Main message

Lower incidences of lymphedema were found in women who exercised regularly, received lymphedema education before treatment, and performed preventive self-care activities.10 Bani et al (2007)14 found that provision of education on lymphedema was associated with use of lymph-drainage massage services. Other factors associated with lower lymphedema incidence and severity included chemotherapy and antiestrogen drugs.15

Two main treatments were identified in the literature for the management of breast cancer–related lymphedema: complex decongestive therapy (CDT)—also known as combined decongestive therapy and complex decongestive physiotherapy—and exercise. Complex decongestive therapy has 4 components: manual lymphatic drainage (MLD); compression therapy; remedial arm and shoulder exercises; and deep-breathing exercises to promote venous and lymphatic flow.42 There are 2 CDT phases: the intensive first phase includes all 4 components provided by lymphedema therapists; in the second, or maintenance, phase the patient practises self-care, with periodic MLD by a therapist. Prescribed exercises aim to restore wrist, forearm, arm, shoulder, cervical, and thoracic trunk range of motion (ROM) and strength. The literature on CDT did not consistently describe the exercises prescribed or the use of MLD.

Complex decongestive therapy

Current evidence supports the use of CDT to improve QOL,43 reduce lymphatic volume,42,44 and increase patients’ intention to exercise.45 However the quality of the literature on CDT varied considerably (Table 2).42–52 Many studies simply described CDT’s effects rather than comparing treatment approaches. Didem et al (2005) were unable to demonstrate that CDT was superior to standard practice (exercise without MLD) to improve shoulder mobility.48 In CDT’s maintenance phase, patients monitor their own conditions and practise self-care49; reduced compliance during this phase can result in increased lymphedema.49,50 Bernas et al (2005)53 described massage therapy for lymphedema management.

View this table:
Table 2.

Key findings on the role of complex decongestive therapy in lymphedema

Two studies investigated whether ongoing local disease can be influenced by CDT47 and MLD,46 concluding that there is no scientific evidence of increased metastasis due to either and that both are safe. Other important findings were that RT does not negatively affect the effects of CDT51 and that the most substantial lymphedema reduction occurs within the first 3 days of intensive MLD,52 suggesting that the intensive phase’s optimal duration might be shorter than currently practised.

The literature indicates that physiotherapists play an important role in the prevention, early detection, and treatment of secondary lymphedema in cancer patients.54–57 Treatment guidelines are available online58 and in the literature.59

Exercise

Supervised exercise programs for patients with lymphedema aim to restore ROM, increase muscle strength, restore or maximize upper extremity function, and control swelling. Weight reduction alone helps lessen lymphedema.60,61 This is important because exercise and weight reduction have been shown to help prevent breast cancer62–65 and improve survival.66–71 Supervised exercise can be individualized or group-based; however, to address patients’ specific limitations, individualized ROM programs are advised. Although the quality of the research on the effects of exercise in women with breast cancer is higher than that evaluating CDT (Table 3),72–81 the literature does not detail the exercises prescribed.

View this table:
Table 3.

Key findings on the role of exercise in lymphedema

Range of motion: In the studies reviewed, postoperative rehabilitation primarily improved shoulder flexion, abduction, and external rotation. The reviewed literature lacks details of the exercises, their intensity, progression methods, or optimal group sizes. Where details were provided, exercise sessions ranged from 45 to 60 minutes, 2 to 3 times per week, for 6 to 12 weeks.

Studies have found that immediate postoperative initiation of ROM exercises improved upper extremity mobility, shoulder function, and QOL.73,74,76 Furthermore, early intervention did not increase postoperative complications such as infections, scar development, or lymphedema.73,74,76 A randomized controlled trial by Lauridsen et al (2005)75 found that patients who started exercising either 6 or 26 weeks after surgery improved ROM without increasing lymphedema. This suggests that starting exercise many weeks after surgery is beneficial; however, the authors did not compare the effects of early initiation with delayed exercise.

Kilgour et al (2008)74 demonstrated that a home-based exercise program is beneficial in the first 2 weeks after surgery, but did not compare this with supervised exercise. Other studies76,78 found that supervised or directed early therapy was superior to self-directed exercise in the immediate postoperative period.

Resistance and strengthening: Historically, after breast cancer surgery, patients were advised to avoid strenuous activity and exercises on the affected side to reduce the risk of lymphedema development or exacerbation. High-quality randomized controlled trials,80,81 supported by other studies,77,79 have demonstrated that resistive exercises neither cause nor worsen lymphedema. Johansson et al (2005)77 found that low-intensity resistance exercises caused a temporary (24-hour) acute increase in lymphedema. Use of compression garments during exercise did not affect this acute lymphedema development.77 The benefits of resistive exercises include reduced lymphedema77 with improvements in self-esteem, physical fitness, body composition,80 QOL,79 and chemotherapy completion rates.80

Some studies that evaluated the effects of resistance prescribed low-intensity exercises77 or progressed them very cautiously.81 Alternately, Courneya et al (2007)80 and Cheema and Gaul (2006)79 prescribed resistive exercises based on estimated 1-repetition maximums (the maximum amount of weight a person can lift in a single repetition), and found no increases in lymphedema. Resistance exercises should address all the main upper extremity muscles.

Other forms of exercise might also be beneficial. Aqua lymphatic therapy helps with lower extremity swelling; however, research supporting its use for upper extremity lymphedema was not found.82 Parbhoo (2006)83 recommended the use of compression garments during swimming or pool therapy. Dance was shown to have neither beneficial nor detrimental effects on lymphedema.84

Other lymphedema treatments

Although exercise should be standard treatment for secondary lymphedema, other options exist. Weight reduction alone is beneficial for reducing lymphedema,60,61 reducing the risk of cancer recurrence,62–65 and improving survival.66–71 Compression garments can be used as part of CDT or alone and are beneficial for subclinical lymphedema.85 Mechanical modalities to reduce arm and breast lymphedema are also available, such as Flexitouch,86,87 Endermologie,88 and Deep Oscillation.89 Invasive techniques might prove beneficial; liposuction combined with controlled compression therapy,90 acupuncture,91 and autologous stem cell transplant92 are currently being investigated.

Patient education

Education about breast cancer complications, including lymphedema, increases patients’ intention to exercise and has a demonstrated effect on lymphedema reduction.93 A Canadian study94 reported that breast cancer patients believed that they received insufficient information about secondary lymphedema. However, providing information does not always translate to increased physical activity,93 suggesting the importance of ongoing education and encouragement by physicians. Recommended patient education topics93–100 outlined in Table 4 are based on current evidence where it is available. Pretreatment education might improve breast cancer survivors’ recall of information about lymphedema.101

View this table:
Table 4.

Patient education topics

Discussion

Breast cancer–related lymphedema is an ongoing challenge for many survivors. A variety of treatments are available for the management of lymphedema, but the evidence supporting them varies. Complex decongestive therapy is a common treatment for lymphedema; however, the evidence supporting it is weaker than that supporting exercise. Based on this review we recommend the following for physicians with breast cancer patients and survivors in their care:

Patient education and referral

Physicians can play a pivotal role as educators by informing breast cancer patients about the risk of secondary lymphedema, prevention strategies, early signs and symptoms, and treatment options. Evidence shows that early intervention is the key to effective treatment. Physicians can also help their patients by referring them to trained health care providers such as physiotherapists or lymphedema therapists.

Exercise prescription and compliance

Exercise guidelines (Table 5) are evidence-informed targets for supervised therapy. As many patients might initially be unable to achieve these levels, exercises must be tailored to individuals’ needs, abilities, and disease status. Preoperative assessment is recommended58 to provide a baseline for postoperative rehabilitation, including exercise prescription. Physicians are encouraged to educate their breast cancer patients about the benefits of regular exercise and healthy weight for secondary lymphedema prevention and management. Ideally, physicians should refer patients to physiotherapists or exercise specialists with knowledge of cancer, its treatment, and rehabilitation.

View this table:
Table 5.

Exercise guidelines

Client-specific exercise prescription is recommended over general low-intensity exercises. The American College of Sports Medicine has published guidelines for cardiorespiratory fitness102 and resistance training.103 Formulas for estimating 1-repetition maximums in older adults are also available.104 Ahmed et al (2006)81 progressed resistance exercises cautiously, and only after measurements showed no increases in lymphedema.

The evidence supports exercise during cancer treatment; however, some patients might have difficulty exercising before their treatment ends. According to Moseley et al (2005),72 gentle arm exercises with deep breathing were effective in reducing lymphedema and had a 90% compliance rate; however, these reductions were not as substantial as those resulting from other treatments.

Conclusion

Secondary lymphedema continues to present a challenge to breast cancer patients and survivors. Several treatment options exist for its management. Although the literature does not identify which treatment is superior, education, exercise, and lymphatic drainage massage are important components of a successful treatment program. Recent research indicates that resistive exercises do not increase incidence or severity of lymphedema, and that such exercises can help manage the side effects of cancer treatment. However, cautious progression of strengthening exercises is essential, ideally with close monitoring by a physiotherapist. Various community-based resources to assist patients who have secondary lymphedema are outlined in Table 6.

View this table:
Table 6.

Lymphedema-related links and resources

Further research on lymphedema management should use designs that minimize biases and identify optimal treatments. To evaluate exercise prescription for lymphedema management, comprehensive information (exercise frequency, duration, mode, intensity, and progression strategy) is required. Future research could identify the exercises with the greatest effect on lymphatic drainage and evaluate efficacy at different stages of cancer treatment. It would also be beneficial for prospective trials to investigate the contribution of exercise to secondary lymphedema prevention, reversal, and management, and the long-term effects of exercise on cancer survivors’ health and well-being.

Acknowledgments

We thank Kathleen Gotts for her extraordinary editing abilities. This article was developed for the Breast Cancer Action (Ottawa) Lymphedema: Take Control project, funded by the Canadian Breast Cancer Foundation—Ontario Region. Breast Cancer Action (Ottawa) has provided support and resources to breast cancer survivors and their families since 1993. For further information about the project, please contact Breast Cancer Action (Ottawa), 301-1390 Prince of Wales Dr, Ottawa, ON K2C 3N6; telephone 613 736-5921; website www.bcaott.ca.

Notes

EDITOR’S KEY POINTS

  • Secondary lymphedema is a common medical complication following treatment of breast cancer and it requires medical attention. Physicians should be able to identify secondary lymphedema, provide basic patient education, and refer patients to other health care providers for further treatment.

  • Lymphedema can be treated with patient education, complex decongestive therapy, self-massage, and exercise.

  • Exercise is a beneficial and safe modality that can be used to prevent and manage secondary lymphedema.

  • Postoperative rehabilitation improves shoulder flexion, abduction, and external rotation and should be offered to all breast cancer patients before commencement of strengthening exercises.

  • Resistance exercises are safe but should be introduced gradually, and lymphedema development should be monitored.

POINTS DE REPÈRE DU RÉDACTEUR

  • Le lymphœdème secondaire est une complication fréquente du traitement du cancer du sein; cette condition requiert une attention médicale. Le médecin devrait être capable d’identifier cette complication, de renseigner adéquatement la patiente et de la diriger vers d’autres intervenants du personnel soignant pour un traitement ultérieur.

  • Le lymphœdème se traite par de l’information à la patiente, un traitement décongestionnant complexe, des massages et de l’exercice.

  • L’exercice peut être utilisée de façon bénéfique et sécuritaire pour prévenir et traiter le lymphœdème.

  • La réadaptation postopératoire améliore la flexion, l’abduction et la rotation externe de l’épaule; on devrait l’offrir dans tous les cas de cancer du sein avant de débuter les exercices de renforcement.

  • Les exercices en résistance sont sécuritaires mais ils devraient être introduits graduellement, tout en surveillant le développement du lymphœdème.

Footnotes

  • This article has been peer reviewed.

  • Cet article a fait l’objet d’une révision par des pairs.

  • This article is eligible for Mainpro-M1 credits. To earn credits, go to www.cfp.ca and click on the Mainpro link.

  • Contributors

    All authors contributed to the literature search and to preparing the manuscript for submission.

  • Competing interests

    None declared

References

  1. 1.↵
    1. Hayes S,
    2. Cornish B,
    3. Newman B
    . Comparison of methods to diagnose lymphoedema among breast cancer survivors: 6-month follow-up. Breast Cancer Res Treat 2005;89(3):221-6.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Hayes S,
    2. Janda M,
    3. Cornish B,
    4. Battistutta D,
    5. Newman B
    . Lymphedema secondary to breast cancer: how choice of measure influences diagnosis, prevalence, and identifiable risk factors. Lymphology 2008;41(1):18-28.
    OpenUrlPubMed
  3. 3.↵
    1. Hayes SC,
    2. Janda M,
    3. Cornish B,
    4. Battistutta D,
    5. Newman B
    . Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function. J Clin Oncol 2008;26(21):3536-42.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Ridner SH
    . Quality of life and a symptom cluster associated with breast cancer treatment-related lymphedema. Support Care Cancer 2005;13(11):904-11. Epub 2005 Apr 6.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Heiney SP,
    2. McWayne J,
    3. Cunningham JE,
    4. Hazlett LJ,
    5. Parrish RS,
    6. Bryant LH,
    7. et al
    . Quality of life and lymphedema following breast cancer. Lymphology 2007;40(4):177-84.
    OpenUrlPubMed
  6. 6.↵
    1. Fu MR
    . Breast cancer survivors’ intentions of managing lymphedema. Cancer Nurs 2005;28(6):446-57.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Thomas-MacLean RL,
    2. Hack T,
    3. Kwan W,
    4. Towers A,
    5. Miedema B,
    6. Tilley A
    . Arm morbidity and disability after breast cancer: new directions for care. Oncol Nurs Forum 2008;35(1):65-71.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Niwinska A,
    2. Tchorzewska H,
    3. Procner M,
    4. Kraszewska E
    . The frequency and risk factors of developing lymphedema of the upper extremity after breast conserving therapy. Nowotwory 2005;55(3):213-8.
    OpenUrl
  9. 9.↵
    1. Clark B,
    2. Sitzia J,
    3. Harlow W
    . Incidence and risk of arm oedema following treatment for breast cancer: a three-year follow-up study. QJM 2005;98(5):343-8. Epub 2005 Apr 8.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Park JH,
    2. Lee WH,
    3. Chung HS
    . Incidence and risk factors of breast cancer lymphoedema. J Clin Nurs 2008;17(11):1450-9.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Paskett ED,
    2. Naughton MJ,
    3. McCoy TP,
    4. Case LD,
    5. Abbott JM
    . The epidemiology of arm and hand swelling in premenopausal breast cancer survivors. Cancer Epidemiol Biomarkers Prev 2007;16(4):775-82.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Ridner SH,
    2. Dietrich MS
    . Self-reported comorbid conditions and medication usage in breast cancer survivors with and without lymphedema. Oncol Nurs Forum 2008;35(1):57-63.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Soran A,
    2. D’Angelo G,
    3. Begovic M,
    4. Ardic F,
    5. Harlak A,
    6. Samuel Wieand H,
    7. et al
    . Breast cancer-related lymphedema—what are the significant predictors and how they affect the severity of lymphedema? Breast J 2006;12(6):536-43.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Bani HA,
    2. Fasching PA,
    3. Lux MM,
    4. Rauh C,
    5. Willner M,
    6. Eder I,
    7. et al
    . Lymphedema in breast cancer survivors: assessment and information provision in a specialized breast unit. Patient Educ Couns 2007;66(3):311-8. Epub 2007 Feb 27.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Vignes S,
    2. Arrault M,
    3. Dupuy A
    . Factors associated with increased breast cancer-related lymphedema volume. Acta Oncol 2007;46(8):1138-42.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Morrell RM,
    2. Halyard MY,
    3. Schild SE,
    4. Ali MS,
    5. Gunderson LL,
    6. Pockaj BA
    . Breast cancer-related lymphedema. Mayo Clin Proc 2005;80(11):1480-4.
    OpenUrlCrossRefPubMed
  17. 17.
    1. Sakorafas GH,
    2. Peros G,
    3. Cataliotti L,
    4. Vlastos G
    . Lymphedema following axillary lymph node dissection for breast cancer. Surg Oncol 2006;15(3):153-65. Epub 2006 Dec 21.
    OpenUrlCrossRefPubMed
  18. 18.
    1. Lane K,
    2. Worsley D,
    3. McKenzie D
    . Exercise and the lymphatic system: implications for breast-cancer survivors. Sports Med 2005;35(6):461-71.
    OpenUrlCrossRefPubMed
  19. 19.
    1. Caban ME,
    2. Yadav R
    . Rehabilitation of breast cancer-related functional deficits. Crit Rev Phys Rehabil Med 2008;20(1):1-23.
    OpenUrl
  20. 20.
    1. Warren AG,
    2. Brorson H,
    3. Borud LJ,
    4. Slavin SA
    . Lymphedema: a comprehensive review. Ann Plast Surg 2007;59(4):464-72.
    OpenUrlCrossRefPubMed
  21. 21.
    1. Cheville AL
    . Current and future trends in lymphedema management: implications for women’s health. Phys Med Rehabil Clin N Am 2007;18(3):539-53, x.
    OpenUrlPubMed
  22. 22.
    1. Moseley AL,
    2. Carati CJ,
    3. Piller NB
    . A systematic review of common conservative therapies for arm lymphoedema secondary to breast cancer treatment. Ann Oncol 2007;18(4):639-46. Epub 2006 Oct 3.
    OpenUrlAbstract/FREE Full Text
  23. 23.
    1. Galvão DA,
    2. Newton RU
    . Review of exercise intervention studies in cancer patients. J Clin Oncol 2005;23(4):899-909.
    OpenUrlAbstract/FREE Full Text
  24. 24.
    1. Cheema B,
    2. Gaul CA,
    3. Lane K,
    4. Fiatarone Singh MA
    . Progressive resistance training in breast cancer: a systematic review of clinical trials. Breast Cancer Res Treat 2008;109(1):9-26. Epub 2007 Jul 12.
    OpenUrlCrossRefPubMed
  25. 25.
    1. Markes M,
    2. Brockow T,
    3. Resch KL
    . Exercise for women receiving adjuvant therapy for breast cancer. Cochrane Database Syst Rev 2006;(4):CD005001.
  26. 26.↵
    1. Bicego D,
    2. Brown K,
    3. Ruddick M,
    4. Storey D,
    5. Wong C,
    6. Harris SR
    . Exercise for women with or at risk for breast cancer-related lymphedema. Phys Ther 2006;86(10):1398-405.
    OpenUrlFREE Full Text
  27. 27.↵
    1. Ward LC
    . Bioelectrical impedance analysis: proven utility in lymphedema risk assessment and therapeutic monitoring. Lymphat Res Biol 2006;4(1):51-6.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Ridner SH,
    2. Montgomery LD,
    3. Hepworth JT,
    4. Stewart BR,
    5. Armer JM
    . Comparison of upper limb volume measurement techniques and arm symptoms between healthy volunteers and individuals with known lymphedema. Lymphology 2007;40(1):35-46.
    OpenUrlPubMed
  29. 29.↵
    1. Tewari N,
    2. Gill PG,
    3. Bochner MA,
    4. Kollias J
    . Comparison of volume displacement versus circumferential arm measurements for lymphoedema: Implications for the SNAC trial. ANZ J Surg 2008;78(10):889-93.
    OpenUrlCrossRefPubMed
  30. 30.↵
    1. Taylor R,
    2. Jayasinghe UW,
    3. Koelmeyer L,
    4. Ung O,
    5. Boyages J
    . Reliability and validity of arm volume measurements for assessment of lymphedema. Phys Ther 2006;86(2):205-14.
    OpenUrlAbstract/FREE Full Text
  31. 31.↵
    1. McKinnon JG,
    2. Wong V,
    3. Temple WJ,
    4. Galbraith C,
    5. Ferry P,
    6. Clynch GS,
    7. et al
    . Measurement of limb volume: laser scanning versus volume displacement. J Surg Oncol 2007;96(5):381-8.
    OpenUrlCrossRefPubMed
  32. 32.↵
    1. Lette J
    . A simple and innovative device to measure arm volume at home for patients with lymphedema after breast cancer. J Clin Oncol 2006;24(34):5434-40.
    OpenUrlAbstract/FREE Full Text
  33. 33.↵
    1. Lette J,
    2. Lette F,
    3. Fraser S
    . Home volumetry foretells a new era of self-management for patients with lymphedema after breast cancer. Lymphology 2007;40(4):185-7.
    OpenUrlPubMed
  34. 34.↵
    1. Beaulac SM,
    2. McNair LA,
    3. Scott TE,
    4. La Morte WW,
    5. Kavanah MT
    . Lymphedema and quality of life in survivors of early stage breast cancer. Arch Surg 2002;137(11):1253-7.
    OpenUrlCrossRefPubMed
  35. 35.↵
    1. Armer J,
    2. Fu MR,
    3. Wainstock JM,
    4. Zagar E,
    5. Jacobes LK
    . Lymphedema following breast cancer treatment, including sentinel lymph node biopsy. Lymphology 2004;37(2):73-91.
    OpenUrlPubMed
  36. 36.↵
    1. Dawes DJ,
    2. Meterissian S,
    3. Goldberg M,
    4. Mayo NE
    . Impact of lymphoedema on arm function and health-related quality of life in women following breast cancer surgery. J Rehabil Med 2008;40(8):651-8.
    OpenUrlPubMed
  37. 37.
    1. Golshan M,
    2. Smith B
    . Prevention and management of arm lymphedema in the patient with breast cancer. J Support Oncol 2006;4(8):381-6.
    OpenUrlPubMed
  38. 38.↵
    1. McLaughlin SA,
    2. Wright MJ,
    3. Morris KT,
    4. Giron GL,
    5. Sampson MR,
    6. Brockway JP,
    7. et al
    . Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol 2008;26(32):5213-9. Erratum in: J Clin Oncol 2010;28(10): 1808.
    OpenUrlAbstract/FREE Full Text
  39. 39.↵
    1. Nesvold IL,
    2. Dahl AA,
    3. Løkkevik E,
    4. Marit Mengshoel A,
    5. Fosså SD
    . Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy. Acta Oncol 2008;47(5):835-42.
    OpenUrlCrossRefPubMed
  40. 40.↵
    1. Sackett DL
    . Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 1986;89(2 Suppl):2S-3S.
    OpenUrlPubMed
  41. 41.↵
    1. Sackett DL,
    2. Rosenberg WM,
    3. Gray JA,
    4. Haynes RB,
    5. Richardson WS
    . Evidence based medicine: what it is and what it isn’t. 1996. Clin Orthop Relat Res 2007;455:3-5.
    OpenUrlPubMed
  42. 42.↵
    1. Koul R,
    2. Dufan T,
    3. Russell C,
    4. Guenther W,
    5. Nugent Z,
    6. Sun X,
    7. et al
    . Efficacy of complete decongestive therapy and manual lymphatic drainage on treatment-related lymphedema in breast cancer. Int J Radiat Oncol Biol Phys 2007;67(3):841-6. Epub 2006 Dec 15.
    OpenUrlCrossRefPubMed
  43. 43.↵
    1. Kim SJ,
    2. Yi CH,
    3. Kwon OY
    . Effect of complex decongestive therapy on edema and the quality of life in breast cancer patients with unilateral lymphedema. Lymphology 2007;40(3):143-51.
    OpenUrlPubMed
  44. 44.↵
    1. Hamner JB,
    2. Fleming MD
    . Lymphedema therapy reduces the volume of edema and pain in patients with breast cancer. Ann Surg Oncol 2007;14(6):1904-8. Epub 2007 Mar 8.
    OpenUrlCrossRefPubMed
  45. 45.↵
    1. Karadibak D,
    2. Yavuzsen T,
    3. Saydam S
    . Prospective trial of intensive decongestive physiotherapy for upper extremity lymphedema. J Surg Oncol 2008;97(7):572-7.
    OpenUrlCrossRefPubMed
  46. 46.↵
    1. Godette K,
    2. Mondry TE,
    3. Johnstone PA
    . Can manual treatment of lymphedema promote metastasis? J Soc Integr Oncol 2006;4(1):8-12.
    OpenUrlPubMed
  47. 47.↵
    1. Pinell XA,
    2. Kirkpatrick SH,
    3. Hawkins K,
    4. Mondry TE,
    5. Johnstone PA
    . Manipulative therapy of secondary lymphedema in the presence of locoregional tumors. Cancer 2008;112(4):950-4.
    OpenUrlCrossRefPubMed
  48. 48.↵
    1. Didem K,
    2. Ufuk YS,
    3. Serdar S,
    4. Zümre A
    . The comparison of two different physiotherapy methods in treatment of lymphedema after breast surgery. Breast Cancer Res Treat 2005;93(1):49-54.
    OpenUrlCrossRefPubMed
  49. 49.↵
    1. Johnstone PA,
    2. Hawkins K,
    3. Hood S
    . Role of patient adherence in maintenance of results after manipulative therapy for lymphedema. J Soc Integr Oncol 2006;4(3):125-9.
    OpenUrlPubMed
  50. 50.↵
    1. Vignes S,
    2. Porcher R,
    3. Arrault M,
    4. Dupuy A
    . Long-term management of breast cancer-related lymphedema after intensive decongestive physiotherapy. Breast Cancer Res Treat 2007;101(3):285-90. Epub 2006 Jul 7.
    OpenUrlCrossRefPubMed
  51. 51.↵
    1. Thomas RC,
    2. Hawkins K,
    3. Kirkpatrick SH,
    4. Mondry TE,
    5. Gabram-Mendola S,
    6. Johnstone PA
    . Reduction of lymphedema using complete decongestive therapy: roles of prior radiation therapy and extent of axillary dissection. J Soc Integr Oncol 2007;5(3):87-91.
    OpenUrlCrossRefPubMed
  52. 52.↵
    1. Yamamoto T,
    2. Todo Y,
    3. Kaneuchi M,
    4. Handa Y,
    5. Watanabe K,
    6. Yamamoto R
    . Study of edema reduction patterns during the treatment phase of complex decongestive physiotherapy for extremity lymphedema. Lymphology 2008;41(2):80-6.
    OpenUrlPubMed
  53. 53.↵
    1. Bernas M,
    2. Witte M,
    3. Kriederman B,
    4. Summers P,
    5. Witte C
    . Massage therapy in the treatment of lymphedema. IEEE Eng Med Biol Mag 2005;24(2):58-68.
    OpenUrl
  54. 54.↵
    1. Gomide LB,
    2. Matheus JP,
    3. Candido dos Reis FJ
    . Morbidity after breast cancer treatment and physiotherapeutic performance. Int J Clin Pract 2007;61(6):972-82.
    OpenUrlPubMed
  55. 55.
    1. Johansson K
    . Is physiotherapy useful to the breast cancer patient? Acta Oncol 2005;44(5):423-4.
    OpenUrlPubMed
  56. 56.
    1. McCallin M,
    2. Johnston J,
    3. Bassett S
    . How effective are physiotherapy techniques to treat established secondary lymphoedema following surgery for cancer? A critical analysis of the literature. N Z J Physiother 2005;33(3):101-12.
    OpenUrl
  57. 57.↵
    1. Suhag V
    . Palliative therapy in cancer patients: an overview. JK Science 2005;7(2):67-72.
    OpenUrl
  58. 58.↵
    1. BC Cancer Agency
    . Upper extremity rehabilitation after axillary dissection. Cancer management guidelines. Vancouver, BC: BC Cancer Agency; 2007. Available from: www.bccancer.bc.ca/HPI/CancerManagementGuidelines/Breast/Physiotherapy/default.htm. Accessed 2010 Nov 8.
  59. 59.↵
    1. Harris SR,
    2. Hugi MR,
    3. Olivotto IA,
    4. Levine M,
    5. Steering Committee for Clinical Practice Guidelines for the Care and Treatment of Breast Cancer
    . Clinical practice guidelines for the care and treatment of breast cancer: 11. Lymphedema. CMAJ 2001;164(2):191-9.
    OpenUrlAbstract/FREE Full Text
  60. 60.↵
    1. Shaw C,
    2. Mortimer P,
    3. Judd PA
    . Randomized controlled trial comparing a low-fat diet with a weight-reduction diet in breast cancer-related lymphedema. Cancer 2007;109(10):1949-56.
    OpenUrlCrossRefPubMed
  61. 61.↵
    1. Shaw C,
    2. Mortimer P,
    3. Judd PA
    . A randomized controlled trial of weight reduction as a treatment for breast cancer-related lymphedema. Cancer 2007;110(8):1868-74.
    OpenUrlPubMed
  62. 62.↵
    1. Batty D,
    2. Thune I
    . Does physical activity prevent cancer? Evidence suggests protection against colon cancer and probably breast cancer. BMJ 2000;321(7274):1424-5.
    OpenUrlFREE Full Text
  63. 63.
    1. Irwin ML
    . Randomized controlled trials of physical activity and breast cancer prevention. Exerc Sport Sci Rev 2006;34(4):182-93.
    OpenUrlCrossRefPubMed
  64. 64.
    1. Kruk J
    . Physical activity in the prevention of the most frequent chronic diseases: an analysis of the recent evidence. Asian Pac J Cancer Prev 2007;8(3):325-38.
    OpenUrlPubMed
  65. 65.↵
    1. Cummings SR
    . Primary prevention of breast cancer: new approaches. Maturitas 2007;57(1):39-41. Epub 2007 Mar 27.
    OpenUrlCrossRefPubMed
  66. 66.↵
    1. Abrahamson PE,
    2. Gammon MD,
    3. Lund MJ,
    4. Britton JA,
    5. Marshall SW,
    6. Flagg EW,
    7. et al
    . Recreational physical activity and survival among young women with breast cancer. Cancer 2006;107(8):1777-85.
    OpenUrlCrossRefPubMed
  67. 67.
    1. Demark-Wahnefried W
    . Cancer survival: time to get moving? Data accumulate suggesting a link between physical activity and cancer survival. J Clin Oncol 2006;24(22):3517-8. Epub 2006 Jul 5.
    OpenUrlFREE Full Text
  68. 68.
    1. Holick CN,
    2. Newcomb PA,
    3. Trentham-Dietz A,
    4. Titus-Ernstoff L,
    5. Bersch AJ,
    6. Stampfer MJ,
    7. et al
    . Physical activity and survival after diagnosis of invasive breast cancer. Cancer Epidemiol Biomarkers Prev 2008;17(2):379-86. Epub 2008 Feb 4.
    OpenUrlAbstract/FREE Full Text
  69. 69.
    1. Holmes MD,
    2. Chen WY,
    3. Feskanich D,
    4. Kroenke CH,
    5. Colditz GA
    . Physical activity and survival after breast cancer diagnosis. JAMA 2005;293(20):2479-86.
    OpenUrlCrossRefPubMed
  70. 70.
    1. Linos E,
    2. Holmes MD,
    3. Willett WC
    . Diet and breast cancer. Curr Oncol Rep 2007;9(1):31-41.
    OpenUrlPubMed
  71. 71.↵
    1. Barbaric M,
    2. Brooks E,
    3. Moore L,
    4. Cheifetz O
    . Effects of physical activity on cancer survival: a systematic literature review. Physiother Can 2010;62(1):25-34.
    OpenUrlCrossRefPubMed
  72. 72.↵
    1. Moseley AL,
    2. Piller NB,
    3. Carati CJ
    . The effect of gentle arm exercise and deep breathing on secondary arm lymphedema. Lymphology 2005;38(3):136-45.
    OpenUrlPubMed
  73. 73.↵
    1. Gordon LG,
    2. Battistutta D,
    3. Scuffham P,
    4. Tweeddale M,
    5. Newman B
    . The impact of rehabilitation support services on health-related quality of life for women with breast cancer. Breast Cancer Res Treat 2005;93(3):217-26.
    OpenUrlCrossRefPubMed
  74. 74.↵
    1. Kilgour RD,
    2. Jones DH,
    3. Keyserlingk JR
    . Effectiveness of a self-administered, home-based exercise rehabilitation program for women following a modified radical mastectomy and axillary node dissection: a preliminary study. Breast Cancer Res Treat 2008;109(2):285-95. Epub 2007 Jul 11.
    OpenUrlCrossRefPubMed
  75. 75.↵
    1. Lauridsen MC,
    2. Christiansen P,
    3. Hessov I
    . The effect of physiotherapy on shoulder function in patients surgically treated for breast cancer: a randomized study. Acta Oncol 2005;44(5):449-57.
    OpenUrlCrossRefPubMed
  76. 76.↵
    1. Cinar N,
    2. Seckin U,
    3. Keskin D,
    4. Bodur H,
    5. Bozkurt B,
    6. Cengiz O
    . The effectiveness of early rehabilitation in patients with modified radical mastectomy. Cancer Nurs 2008;31(2):160-5.
    OpenUrlCrossRefPubMed
  77. 77.↵
    1. Johansson K,
    2. Tibe K,
    3. Weibull A,
    4. Newton RC
    . Low intensity resistance exercise for breast cancer patients with arm lymphedema with or without compression sleeve. Lymphology 2005;38(4):167-80.
    OpenUrlPubMed
  78. 78.↵
    1. De Rezende LF,
    2. Franco RL,
    3. de Rezende MF,
    4. Beletti PO,
    5. Morais SS,
    6. Gurgel MS
    . Two exercise schemes in postoperative breast cancer: comparison of effects on shoulder movement and lymphatic disturbance. Tumori 2006;92(1):55-61.
    OpenUrlPubMed
  79. 79.↵
    1. Cheema BS,
    2. Gaul CA
    . Full-body exercise training improves fitness and quality of life in survivors of breast cancer. J Strength Cond Res 2006;20(1):14-21.
    OpenUrlCrossRefPubMed
  80. 80.↵
    1. Courneya KS,
    2. Segal RJ,
    3. Mackey JR,
    4. Gelmon K,
    5. Reid RD,
    6. Friedenreich CM,
    7. et al
    . Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J Clin Oncol 2007;25(28):4396-404. Epub 2007 Sep 4.
    OpenUrlAbstract/FREE Full Text
  81. 81.↵
    1. Ahmed RL,
    2. Thomas W,
    3. Yee D,
    4. Schmitz KH
    . Randomized controlled trial of weight training and lymphedema in breast cancer survivors. J Clin Oncol 2006;24(18):2765-72. Epub 2006 May 15.
    OpenUrlAbstract/FREE Full Text
  82. 82.↵
    1. Tidhar D,
    2. Drouin J,
    3. Shimony A
    . Aqua lymphatic therapy in managing lower extremity lymphedema. J Support Oncol 2007;5(4):179-83.
    OpenUrlPubMed
  83. 83.↵
    1. Parbhoo S
    . Lymphoedema in young patients with breast cancer. Breast 2006;15(Suppl 2):S61-4.
    OpenUrlPubMed
  84. 84.↵
    1. Sandel SL,
    2. Judge JO,
    3. Landry N,
    4. Faria L,
    5. Ouellette R,
    6. Majczak M
    . Dance and movement program improves quality-of-life measures in breast cancer survivors. Cancer Nurs 2005;28(4):301-9.
    OpenUrlPubMed
  85. 85.↵
    1. Stout Gergich NL,
    2. Pfalzer LA,
    3. McGarvey C,
    4. Springer B,
    5. Gerber LH,
    6. Soballe P
    . Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer 2008;112(12):2809-19.
    OpenUrlCrossRefPubMed
  86. 86.↵
    1. Wilburn O,
    2. Wilburn P,
    3. Rockson SG
    . A pilot, prospective evaluation of a novel alternative for maintenance therapy of breast cancer-associated lymphedema [ISRCTN76522412]. BMC Cancer 2006;6:84.
    OpenUrlCrossRefPubMed
  87. 87.↵
    1. Ridner SH,
    2. McMahon E,
    3. Dietrich MS,
    4. Hoy S
    . Home-based lymphedema treatment in patients with cancer-related lymphedema or noncancer-related lymphedema. Oncol Nurs Forum 2008;35(4):671-80.
    OpenUrlCrossRefPubMed
  88. 88.↵
    1. Moseley AL,
    2. Esplin M,
    3. Piller NB,
    4. Douglass J
    . Endermologie (with and without compression bandaging)—a new treatment option for secondary arm lymphedema. Lymphology 2007;40(3):129-37.
    OpenUrlPubMed
  89. 89.↵
    1. Jahr S,
    2. Schoppe B,
    3. Reisshauer A
    . Effect of treatment with low-intensity and extremely low-frequency electrostatic fields (Deep Oscillation) on breast tissue and pain in patients with secondary breast lymphoedema. J Rehabil Med 2008;40(8):645-50.
    OpenUrlCrossRefPubMed
  90. 90.↵
    1. Brorson H,
    2. Ohlin K,
    3. Olsson G,
    4. Långström G,
    5. Wiklund I,
    6. Svensson H
    . Quality of life following liposuction and conservative treatment of arm lymphedema. Lymphology 2006;39(1):8-25.
    OpenUrlPubMed
  91. 91.↵
    1. Alem M,
    2. Gurgel MS
    . Acupuncture in the rehabilitation of women after breast cancer surgery—a case series. Acupunct Med 2008;26(2):86-93.
    OpenUrlAbstract/FREE Full Text
  92. 92.↵
    1. Hou C,
    2. Wu X,
    3. Jin X
    . Autologous bone marrow stromal cells transplantation for the treatment of secondary arm lymphedema: a prospective controlled study in patients with breast cancer related lymphedema. Jpn J Clin Oncol 2008;38(10):670-4. Epub 2008 Sep 5.
    OpenUrlAbstract/FREE Full Text
  93. 93.↵
    1. Basen-Engquist K,
    2. Taylor CL,
    3. Rosenblum C,
    4. Smith MA,
    5. Shinn EH,
    6. Greisinger A,
    7. et al
    . Randomized pilot test of a lifestyle physical activity intervention for breast cancer survivors. Patient Educ Couns 2006;64(1–3):225-34. Epub 2006 Jul 14.
    OpenUrlCrossRefPubMed
  94. 94.↵
    1. Thomas-MacLean R,
    2. Miedema B,
    3. Tatemichi SR
    . Breast cancer–related lymphedema. Women’s experiences with an underestimated condition. Can Fam Physician 2005;51:246-7.
    OpenUrlAbstract/FREE Full Text
  95. 95.
    1. Perdue C,
    2. Noble S
    . Foreign travel for advanced cancer patients: a guide for healthcare professionals. Postgrad Med J 2007;83(981):437-44.
    OpenUrlAbstract/FREE Full Text
  96. 96.
    1. Nielsen I,
    2. Gordon S,
    3. Selby A
    . Breast cancer-related lymphoedema risk reduction advice: a challenge for health professionals. Cancer Treat Rev 2008;34(7):621-8. Epub 2008 Aug 8.
    OpenUrlPubMed
  97. 97.
    1. Cohen S
    . Managing lymphedema, a lingering problem for breast cancer patients. Community Oncol 2006;3(5):304-7.
    OpenUrl
  98. 98.
    1. Lymphoedema Framework
    . International consensus. Best practice for the management of lymphoedema. London, UK: Medical Education Partnership Ltd; 2006.
  99. 99.
    1. National Lymphedema Network
    . Position statement of the National Lymphedema Network. Lymphedema risk reduction practices. San Francisco, CA: National Lymphedema Network; 2010. Available from: www.lymphnet.org/pdfDocs/nlnriskreduction.pdf. Accessed 2010 Nov 8.
  100. 100.↵
    1. National Lymphedema Network
    . Position statement of the National Lymphedema Network. Air travel. San Francisco, CA: National Lymphedema Network; 2010. Available from: www.lymphnet.org/pdfDocs/nlnairtravel.pdf. Accessed 2010 Nov 8.
  101. 101.↵
    1. Ridner SH
    . Pretreatment lymphedema education and identified educational resources in breast cancer patients. Patient Educ Couns 2006;61(1):72-9.
    OpenUrlCrossRefPubMed
  102. 102.↵
    1. American College of Sports Medicine position stand
    . The recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness, and flexibility in healthy adults. Med Sci Sports Exerc 1998;30(6):975-91.
    OpenUrlCrossRefPubMed
  103. 103.↵
    1. Kraemer WJ,
    2. Adams K,
    3. Cafarelli E,
    4. Dudley GA,
    5. Dooly C,
    6. Feigenbaum MS,
    7. et al
    . American College of Sports Medicine position stand. Progression models in resistance training for healthy adults. Med Sci Sports Exerc 2002;34(2):364-80.
    OpenUrlCrossRefPubMed
  104. 104.↵
    1. Heyward VH
    . Advanced fitness assessment and exercise prescription. 5th ed. Champaign, IL: Human Kinetics Inc; 2006.
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Respond to this article
Management of secondary lymphedema related to breast cancer
Oren Cheifetz, Louise Haley, Breast Cancer Action
Canadian Family Physician Dec 2010, 56 (12) 1277-1284;
Twitter logo Facebook logo Mendeley logo

Jump to section